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Abstract The growth of calcium oxalate monohydrate in
the presence of Tamm-Horsfall protein (THP), osteopontin,
and the 27-residue synthetic peptides (DDDS)6DDD and
(DDDG)6DDD (D = aspartic acid, S = serine, and
G = glycine) was investigated via in situ atomic force
microscopy. The results show that these four growth mod-
ulators create extensive deposits on the crystal faces.
Depending on the modulator and crystal face, these deposits
can occur as discrete aggregates, ﬁlamentary structures, or
uniform coatings. These proteinaceous ﬁlms can lead to
eitherthe inhibitionoforanincreaseinthestepspeeds(with
respecttotheimpurity-freesystem),dependingonarangeof
factors that include peptide or protein concentration, super-
saturation, and ionic strength. While THP and the linear
peptidesact,respectively,toexclusivelyincreaseandinhibit
growth on the  101 ðÞ face, both exhibit dual functionality on
the (010) face, inhibiting growth at low supersaturation or
high modulator concentration and accelerating growth at
high supersaturation or low modulator concentration. Based
on analyses of growth morphologies and dependencies of
step speeds on supersaturation and protein or peptide con-
centration, we propose a picture of growth modulation that
accounts for the observations in terms of the strength of
binding to the surfaces and steps and the interplay of elec-
trostatic and solvent-induced forces at the crystal surface.
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Although naturally occurring macromolecules in urine [1],
such as osteopontin (OPN) and Tamm-Horsfall glycopro-
tein (THP), are believed to play an important role in
controlling stone formation, a mechanistic understanding is
missing. Numerous in vitro studies have shown that OPN
strongly inhibits the nucleation and growth of calcium
oxalate monohydrate—the most abundant mineral phase in
urinary stones [2]. Stones are often found attached to epi-
thelial cells and are typically aggregates of smaller crystals
containing matrices of proteins, carbohydrates, and lipids
[3]. A role for these macromolecular constituents in either
promoting or inhibiting aggregation and/or attachment to
cell membranes has been proposed [4, 5]. Indeed, some in
vitro studies have concluded that THP, which is the most
common protein found in human urine [6], does not inhibit
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DOI 10.1007/s00223-009-9223-0COM crystal growth [7, 8] but acts to inhibit aggregation [9,
10] or to limit the attachment of existing crystals to cell
surfaces [11–13]. Others concluded that THP plays no role
in COM growth [8]. A number of studies provide direct
evidence that both OPN and THP themselves readily attach
to the COM surface [3, 14]. For example, using SDS-PAGE
and Western blotting, Ryall et al. [15] observed that THP
adhered to COM crystals taken from urine, and that ‘‘scru-
pulous care mustbe taken to ensure the complete removal of
extraneous THP adventitiously associated with CaOx
crystals ….’’ Using atomic force microscopy, Qiu et al. [14]
foundthatOPNatnanomolarconcentrations condensedinto
clusters 10–50 nm in diameter and 1 nm in height on the
( 101)faceofCOM.Inanotherstudy,Shengetal.[16],using
chemical-force microscopy to investigate the binding of
various functional groups to COM surfaces, found strong
binding by carboxyl groups to COM surfaces, with the
strongest adhesion force occurring on the ( 101) face.
Taken together, these observations suggest that, if these
proteins play a role in promoting or inhibiting COM
aggregation or attachment to cell membranes, those prop-
erties may be related to a propensity for the proteins
themselves to attach to the surface. In order to clarify the
effects of OPN and THP on growth kinetics, gain insight
into the relationship between protein adhesion and growth
modulation, and identify factors that lead to protein
aggregation, we have used in situ atomic force microscopy
(AFM) to investigate growth of COM in the presence of
THP, OPN, and two peptides. The latter were synthetic 27-
residue aspartic-acid-rich linear peptides designed to act as
surrogates for the aspartic-acid-rich segments of OPN,
which contains subsequences characterized by runs of two
and three aspartic acid residues, often separated by serine or
glycine [7]. The results show that the formation of pro-
teinaceous ﬁlms and surface aggregates is a common
phenomenon for aspartic-acid-rich peptides and proteins in
the COM system, but that the tendency toward aggregate
formation depends strongly on electrostatic interactions.
Moreover, these biomolecules exhibit inhibitory or
enhancing effects on kinetics that are often counter-intuitive
based on the structure of the crystal face and the charge state
of the peptide or protein. But regardless of whether the
impact on kinetics is enhancing or inhibitory, these surface-
adsorbed proteins can be expected to have a signiﬁcant
impact on crystal aggregation and attachment to cells.
Materials and Methods
Peptide Synthesis and Protein Puriﬁcation
Aspartic-acid-rich peptides with serine or glycine spacers
were synthesized according to standard procedures [17, 18]
by sequential addition of Fmoc amino acids. Following
synthesis, the peptides were puriﬁed and molecular weights
veriﬁed by mass spectrometry as described previously [18].
The condensed formulae for the peptides are (DDDS)6DDD
and (DDDG)6DDD, where D = aspartic acid, S = serine,
and G = glycine. The molecular masses of the peptides
were 2,955 and 2,775 Da for (DDDS)6DDD and
(DDDG)6DDD, respectively, as determined by mass spec-
trometry and agreed with the expected values to within
99.998%.
OPN was isolated by immunoafﬁnity puriﬁcation as
described [19]. Aliquots of OPN solutions were stored at
80 C before use. THP was isolated from 24-h collections of
normal human urine obtained with 0.01% thimerosal added
as a preservative. Isolation procedures were monitored by
quantitative analysis of THP concentrations performed by
ELISA using a polyclonal rabbit anti-THP as the primary
antibody [20]. Puriﬁcation from whole urine followed the
procedure originally described by Tamm and Horsfall [21]
by raising the salt concentration to 0.58 M by the addition
of NaCl, mixing, and storing the mixture overnight at 4 C
before centrifugation at 5,000 g for 30 min. The precipitate
of THP was washed twice with 0.58 M NaCl and centri-
fuged after each wash. After dissolving THP by the
addition of deionized water and centrifuging, the pellet was
discarded and the supernatant was dialyzed against deion-
ized water containing 0.02% sodium azide and then
precipitated again by raising the NaCl concentration to
0.58 M. These steps were repeated so that each sample of
THP was precipitated at least ﬁve times before the ﬁnal
dialysis against deionized water containing 0.02% sodium
azide.
With the exception of our own work [7], all published
studies of calcium oxalate crystallization have used THP
obtained through standard salt-precipitation method. The
THP obtained through salt precipitation (spTHP) [21]
migrates in a single band in SDS-PAGE gels. Immunoas-
says conﬁrm that this standard method achieves only
partial depletion of THP from urine; previous studies,
therefore, did not evaluate the full urinary repertoire of
THP molecules. Therefore we also prepared immunoaf-
ﬁnity-puriﬁed protein (apTHP). The supernatant after the
initial salt precipitation of THP from urine was partially
fractionated by adsorption to DEAE-cellulose, batch-
eluted, and dialyzed against a 0.05 M Tris, 0.05 M NaCl,
pH 7.3, buffer prior to immunopuriﬁcation as previously
described [7]. Monoclonal anti-THP beads (5 mg IgG/ml
Sepharose beads) were prepared as previously described
[7]. The B1 fractions of urinary proteins [7] were exposed
to anti-THP beads in a Kontes Flex Column by slow cir-
cular rotation for 30 min. The anti-THP beads were then
extensively washed with Tris buffer prior to elution with
0.05 M diethylamine, pH 11.5. Eluates were neutralized
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123and then dialyzed against deionized water containing
0.02% sodium azide. In SDS-PAGE gels, this apTHP
migrates in the same position as the spTHP and, also, in an
additional band that migrates *10 kD farther. (In addition
to apTHP, proteins with other functional activities have
also been shown to fully share a primary peptide sequence
with THP; these proteins, or subfractions of THP, were also
isolated by methods other than salt precipitation [22, 23].)
COM Crystal and Solution Preparation
The COM crystals used for these experiments were grown
in vitro using a gel method [24]. A schematic showing their
typical habit is given in Fig. 1. For in situ AFM experi-
ments in aqueous solution, CaC2O4   H2O solutions
(calcium-to-oxalate ratio = 1) were prepared using
reagent-grade K2C2O4 and CaCl2   2H2O dissolved in
distilled deionized (18 MX) water. The calcium and oxa-
late concentrations were varied from 0.1 to 0.4 mM,
corresponding to a range of supersaturation from -0.2 to
1.5. Supersaturation is deﬁned as
r ¼
1
2
ln
aCa2þ   aC2O2 
4
Ksp
  
ð1Þ
where Ksp is the solubility product for COM at room
temperature and was determined from the ionic activities at
which step speed was equal to 0 (Ksp = 1.66 9 10
-9 M
2
[25]). The ionic activities, aCa2þand aC2O2 
4 , are calculated
by successive approximation of the ionic strength using the
Davies equation and mass balance expressions for total
calcium and total oxalate with appropriate equilibrium
constants.
The concentrations of proteins used in this study were
chosen according to physiological ranges. THP concen-
trations ranged from 10 to 100 nM, which is on the low end
of the physiological range [8, 20]. OPN concentrations
ranged from 1 to 25 nM, which is similar to the physio-
logical range. Peptide concentrations were chosen based on
the magnitude of their effects over the supersaturation
range used for the protein studies. Concentration ranges of
2 to 10 nM and 40 to 200 nM were used for (DDDS)6DDD
and (DDDG)6DDD, respectively.
The pH of all solutions was adjusted to 7.00 ± 0.05
before each experiment using a calibrated glass electrode
and KOH. The ionic strength of the growth solutions was
adjusted to 0.05 or 0.15 M by the addition of KCl. Ionic
strength, I, is deﬁned as
I ¼ 0:5  
X n
i
ciz2
i ð2Þ
where zi and ci represent the ionic charge of each ‘ith’
species and the concentration of each species, respectively.
Inductively coupled plasma atomic-emission spectroscopy
was used to conﬁrm the purity of all chemicals.
In Situ AFM Imaging
AFM observations were made on dislocation hillocks of the
( 101) and (010) faces [14] (Fig. 1). All in situ images were
collected in contact mode (Nanoscope E or IIIA; Veeco
Instruments, Santa Barbara, CA) on crystals anchored
inside an enclosed ﬂuid cell. SiN4 cantilevers and tips were
used in all rate studies. The temperature was held constant
at 25 C using a ﬂow-through Peltier device. The images
were obtained while supersaturated solutions ﬂowed
through the system. The ﬂow rate (*2 ml/min) was
adjusted to ensure that growth was limited by surface
kinetics and not by diffusion [26]. That is, at a given
supersaturation, the step speed did not change when the
ﬂow rate was increased [27].
Fig. 1 Schematic of a synthetic
COM crystal showing the three
expressed faces and
crystallographic axes, along
with AFM images of typical
hillocks on the two major faces
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123Several precautions were taken to ensure that the AFM
images were authentic representations of the surface mor-
phology and step velocities. First, the imaging force was
reduced to the minimum possible value that allowed the tip
to remain in contact with the surface so that there was no
measurable effect of tip movement on the growth kinetics.
The absence of an effect was veriﬁed by gradually
increasing the force until effects on morphology and step
speed were observed, by reducing the force until the tip
pulled away from the surface, or by zooming out to a larger
scan box and looking for the signature of the smaller scan
area. A consequence of imaging in this regime is that the
tip can transiently detach from the surface. The image
quality is diminished slightly but the light force exerted on
the sample by the tip ensures that the morphology and
kinetics of the steps are minimally affected. Next, images
were collected at different scan angles, and both trace and
retrace images were regularly compared. This procedure
eliminated the possibility that imaging artifacts arose from
tip contamination or from the tip sticking to the surface.
Furthermore, step speed was estimated from images that
were collected at a large and a small scale to ensure that
there was no effect from scanning. Because the images
were taken in real time, it is inevitable that distortion of the
step orientation will exist in the images. Such distortion is
caused by step movement during the ﬁnite scan time, so
that the apparent step orientation differs from the true
orientation. The images reported here were not corrected
for this effect. In fact, we use this change in angle to extract
the step velocities under certain growth conditions [27].
Results
Tamm-Horsfall Protein
Figure 2 shows the temporal evolution of the surface
morphology on the ( 101) face following introduction of an
apTHP-containing solution. Although the hillock shape
remained unchanged, aggregates of THP adsorbed onto the
face. At a sufﬁciently high protein concentration, the face
became completely covered. Typically, the aggregates took
on an irregular ﬁlamentary shape with a dominant orien-
tation along the (010) direction (parallel to the [101] step
edge).
The time at which proteins began to be visible on the
surface depended on the protein concentration. For exam-
ple, at a concentration of 10 nM, the minimum time
required for apTHP to be observable on the face was about
27 min. In contrast, when a supersaturated solution con-
taining 100 nM apTHP was introduced, aggregates were
visible on the ( 101) surface as soon as imaging began
(*1 min). As shown in Fig. 2d, the surface became
completely covered with protein after only 4–5 min. Sur-
prisingly, although the surface was fully covered with
apTHP, the triangular growth hillock is still clearly dis-
cernible. In fact, up until the time when the steps were no
longer visible, the shape of the step edges was preserved,
and the step edges in all three directions were still
advancing with no obvious change in speed.
In contrast to what was observed on the ( 101) face,
aggregates did not form on the (010) face following
Fig. 2 Growth hillock on the
( 101) face of COM after a
0 min, b 1.5 min, c 3 min, and
d 4.5 min of exposure to
100 nM apTHP. Horizontal
dimension of images = 3.5 lm.
The labeled arrow in a indicates
the [101] direction
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123introduction of apTHP solution. The absence of aggregates
on the (010) surface is shown in Fig. 3, which displays the
change in growth hillock morphology with increasing
protein concentrations. However, with increasing THP
concentration, the steps became increasingly less distinct
(Fig. 3c, d). The only reasonable conclusion we can draw
from these changes is that the surface became covered in a
thin ﬁlm of THP. As in the case of the ( 101) surface, even
at the highest THP concentrations, this ﬁlm had only a
minor impact on the step morphology or speed.
Measurements of the step speeds on the ( 101) face as a
function of supersaturation and protein concentration show
a result that is counter-intuitive. The growth kinetics were
enhanced even when the face was completed coated by
THP aggregates and the steps difﬁcult to resolve. This
enhancement is exhibited in Fig. 4, which shows the
measured speed of the [101] step as a function of solution
supersaturation at two different protein concentrations and
ionic strengths. The trendlines are best ﬁts to each set of
data and show that, for both ionic strengths, while the
equilibrium Ca
2? activity (i.e., the Ca
2? activity at which
the step speed is zero) remained unchanged, the slope was
increased by 20% to 30%.
The effects of apTHP on growth kinetics on the (010)
face differed from those seen on the ( 101) face. As Fig. 5a
and b show, the results obtained for the two types of steps
on that face at an ionic strength of 0.05 M were similar for
both step types. They exhibited a dual functionality, though
the magnitudes of the effects and the crossover points from
inhibition to acceleration differed somewhat. At low cal-
cium activities, there was either no measurable effect
(10 nM) or a slight inhibition (25 and 75 nM). As super-
saturation was increased, the step speed increased for all
three protein concentrations, leading to enhanced growth
rates. However, the magnitude of the acceleration did not
scale proportionally with the concentrations of protein in
solution. Some, if not most, of this lack of scaling was
undoubtedly due to experimental error inherent in the data,
since we were measuring changes of only a few tenths of a
nanometer per second. As the inset in Fig. 5b shows, at the
higher ionic strength of 0.15 M, the results differ slightly in
that no inhibition was observed at the apTHP concentration
Fig. 3 Growth hillock on the
(010) face of COM after 1 h of
exposure to a 0 nM, b 10 nM, c
25 nM, and d 75 nM apTHP. As
apTHP concentration increases,
step edges become difﬁcult to
resolve. The loss of resolution
does not prevent measurement
of step speed. Horizontal
dimension of images = 1 lm.
Labeled arrows in a indicate the
[100] and [021] step directions
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123of 25 nM used to collect the data. However, the shapes of
the curves and the magnitude of the acceleration at higher
calcium activities were very similar.
The effect of spTHP on the growth kinetics of the (010)
face at ionic strength of 0.05 M was also examined for
different protein concentrations. As shown in Fig. 6a, for
the [021] step the dual functionality was still present, but
the trend was reversed. There was slight acceleration at low
calcium activity and inhibition at higher levels. However,
again the magnitude of the changes in step speed did not
scale proportionally with protein concentration. As with
apTHP, some of this can be attributed to scatter in the data.
For the [100] step, the trends are similar, though at the
highest activities the data show a mix of slight inhibition
and acceleration depending on the spTHP concentration
(Fig. 6b). In particular, at the highest supersaturations, all
protein levels gave enhancement except 75 nM, where
inhibition dominated.
Osteopontin
As Fig. 7 shows, introduction of OPN leads to the forma-
tion of aggregates on the ( 101) face. That ﬁgure also shows
how the coverage of aggregates varies with time for con-
centrations of 2 and 5 nM. At a concentration of 2 nM, the
aggregates start out as discrete clusters 10–25 nm in
diameter. With time, these clusters grow in length to form
elongated structures with a dimension along the short axis
remaining near *25 nm and a long axis that trends along
the [010] direction, as was the case with THP. (Compare
Fig. 7c, d with Fig. 2c.) At an OPN level of 5 nM, the
density of the aggregates eventually becomes so high that,
as with THP, the steps are no longer visible.
Figure 8 shows the observed temporal evolution of the
(010) face following introduction of 5 nM OPN. As with
THP, the steps became less distinct after introduction of
OPN (compare with Fig. 3). But unlike THP, step propa-
gation was extensively inhibited at OPN levels of only
5 nM.
Synthetic Linear Aspartic-Acid(Asp)-Rich Peptides
[(DDDX)6DDD]
Finally, we compare the results obtained with THP and
OPN to those obtained with the 27-residue (DDDG)6DDD
peptide. As Fig. 9 shows, on the (010) face, these peptides
created clusters similar to those observed with OPN on the
Fig. 4 The effect of apTHP on the [101] step of the ( 101) face of
COM at ionic strengths of 0.05 and 0.15 M. The slope at 0.15 M ionic
strength is higher than that at 0.05 M ionic strength. At both ionic
strengths the addition of apTHP to the growth solution increases the
step speed with respect to the pure system
Fig. 5 The effect of apTHP on a the [021] step and b the [100] step
of the (010) face of COM at an ionic strength of 0.05 M. For the [021]
step, the addition of apTHP to the growth solution increases the step
speed with respect to the pure system, while for the [100] step, the
speed is depressed by apTHP at lower supersaturations and enhanced
at higher supersaturations. The effect does not scale with apTHP
concentration. Inset in b: The effect of apTHP on the [100] step of the
(010) face of COM at an ionic strength of 0.15 M. Step speed is
accelerated by apTHP
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123( 101) face. As with OPN, the density of clusters increased
with increasing peptide concentration, as did the average
size. Once again, at low concentrations, the step mor-
phology was largely unaffected. But as Fig. 10 shows, the
step speed exhibits dual functionality on this face, as was
the case for THP. Steps are inhibited at low supersaturation
or high peptide levels and accelerated at higher supersat-
uration or low peptide levels (Fig. 10a, b, respectively).
In contrast to the discrete peptide aggregates seen on the
(010) face, on the ( 101) face, the peptides made a contin-
uous ﬁlm, though at high concentrations some isolated
aggregates also formed (Fig. 11). Even at low levels
(40 nM), this peptide caused signiﬁcant inhibition of
growth on this face at low supersaturation. There were
wide regions of positive supersaturation where the step
speed was near zero and steps exhibited extensive pinning
(Fig. 11). But as Fig. 10a shows, with a small increase in
supersaturation (Dr of *0.3), inhibition was no longer
observed and the steps recovered to their full speed.
While the results given here are for only one peptide
concentration and for just the glycine compound, the data
for all other concentrations and the results with
(DDDS)6DDD were found to be qualitatively similar,
though the (DDDS)6DDD concentrations needed to obtain
the same density of clusters or levels of inhibition/accel-
eration were about 40 times lower. The complete data set
and their analysis will be presented in a separate paper.
Discussion
The results presented here for OPN and the Asp-rich
peptides are consistent with our previous work on these
systems. We previously reported that OPN formed adsor-
bed clusters on the ( 101) face of COM [14]. We found that
for a 1 nM concentration of OPN, the clusters were about
1 nm in height, varied in diameter between about 10 and
50 nm, and were spaced tens to hundreds of nanometers
apart, with the density increasing over time. That study also
showed that OPN strongly affected step morphology on the
(010) face, with the steps showing extensive evidence for
step pinning and with step growth inhibited to the point of
complete cessation after 70 min. However, at the concen-
trations used in that work, there was no apparent reduction
in step speed on the ( 101) face, though quantitative mea-
surements were not performed. Similarly, in a previous
study looking at the effect of (DDDS)6DDD and
(DDDG)6DDD [28], we found that the overall morphology
of the (010) face following addition of this peptide was
similar to that seen in Fig. 8 following OPN addition.
However, the dependencies of morphology and step speed
on peptide concentration were not determined and imaging
was only performed at a low resolution. The results pre-
sented here ﬁll these gaps by providing higher-resolution
information about the protein-surface interactions and
quantitative data on the changes in step kinetics.
Clearly, the modiﬁcation in step kinetics by THP
depends on the method by which it is extracted and there
are also slight differences associated with changes in ionic
strength. But the trend is clear. Despite the extensive
coating by the proteins, the kinetics of step growth are
generally accelerated by the presence of THP, although
moderate inhibition can dominate on the (010) face at high
THP concentrations and low supersaturations. These
results provide clues to the possible roles of THP in cal-
cium oxalate stone formation. The likely candidates are
narrowed to the inhibition of crystal attachment and/or
aggregation. The protein coating may account for the
Fig. 6 The effect of spTHP on a the [021] step and b the [100] step
of the (010) face of COM at an ionic strength of 0.05 M. For the [021]
step, speed is accelerated at lower supersaturations and slight
inhibition is observed at higher supersaturations, while for the [100]
step, speed is accelerated, but as supersaturation increases the
magnitude of the acceleration decreases. The effects do not scale
with spTHP concentration
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123inhibitory effect on aggregation that has been observed
previously [9, 10] as well as preventing attachment of
crystals at cell surfaces [11–13]. Additionally, the presence
of THP on the crystal surface may prevent the attachment
of other nucleation-promoting macromolecules.
An obvious question raised by this study is whether the
dual functionality that is observed to a limited extent for
THP and to a much greater degree for the Asp-rich peptides
has a useful function biologically. The ability of an
organism to alternately accelerate or inhibit growth rates on
Fig. 7 Time sequence showing
the development of OPN
aggregates from initial ( 101)
surface morphology (a) at OPN
concentrations of 2 nM (b, c, d)
and 5 nM (e, f). Aggregates are
elongated along the [010]
direction. Image sizes and times
are: as follows.
0 nM: a 9 9 4.5 lm, 0 min.
2 nM: b 2 9 1 lm, 10 min;
c 3 9 1.5 lm, 30 min;
d 3 9 1.5 lm, 40 min.
5 nM: e 9 9 4.5 lm, 10 min;
f 5 9 2.5 lm, 20 min
Fig. 8 Time sequence showing
development of the (010) face at
an OPN concentration of 5 nM.
All image sizes are
1.7 9 1.7 lm and times are a
0 min, b 40 min, c 50 min, and
d 70 min
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123speciﬁc faces with small changes in protein expression
levels has obvious advantages during formation of func-
tional tissues, for controlling both shape and overall size.
But the advantage for limiting pathological mineralization
is not at all clear and it may well be an unintended con-
sequence of the inherent charged nature of COM crystal
faces and the need for protein inhibitors to be rich in highly
charged residues—particularly aspartic acid. The fact that
the sequence of urinary OPN is close that of OPN from
human bone provides some support for this suggestion.
Of the results presented here, the effect of THP on ( 101)
growth kinetics are the most easily analyzed. As the data in
Fig. 4 show, the step speed exhibits linear kinetics. This
linear dependence is expected in the limit where growth is
determined by the rate at which solute molecules leave the
solution and attach to kink sites on the steps. In this case,
one can write [29]:
v ¼ xb a Ca2þ ðÞ   ae Ca2þ ðÞ
  
ð3Þ
where x is the speciﬁc molecular volume of COM, b is the
kinetic coefﬁcient that governs solute attachment kinetics
at the step edge, and a Ca2þ ðÞ   ae Ca2þ ðÞ is the difference in
actual and equilibrium calcium activities. Equation (3)i sa
simpliﬁcation of an equation [30] that includes both cal-
cium and oxalate activities; however, at our experimental
conditions, where the activities of calcium and oxalate are
nearly equal, Eq. (3) is a useful approximation. In this
linear regime, the parameter b is independent of calcium
activity and exhibits an Arrhenius dependence on temper-
ature: b / e  Ea=kBT ðÞ . Consequently, the simplest
interpretation of the data in Fig. 4 is that the activation
barrier to attachment is reduced by the presence of the
peptides. This same conclusion was reached from analysis
of accelerated calcite growth in the presence Asp, poly-
Asp, Asp dipeptides, and (DDDX)6DDD for X = S and G
[31]. Since activation energies for simple salts growing in
solution all appear to be between about 25 and 35 kJ/mol
[29, 32], the level of acceleration seen here amounts to a
change in activation energy of about 0.5 kJ/mol. Though it
is a small fraction of the total barrier, its effect is ampliﬁed
by the exponential dependence of b on Ea.
Fig. 9 Effect of (DDDG)6DDD on growth morphology of the (010) face showing an increase in peptide cluster density with various peptide
concentrations. Image sizes are all 150 9 150 nm
Fig. 10 a Dependence of the step speed normalized to the speed in
the pure system on supersaturation in the presence of (DDDG)6DDD
at a concentration of 100 nM for the [101] step on the ( 101) face and
1 lM for the [021] step on the (010) face. b Scaling of [100] step
speed enhancement or inhibition with peptide concentration
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123The inhibition of step growth on the ( 101) face by
(DDDG)6DDD and (DDDS)6DDD is also easy to under-
stand. The mechanism of inhibition is essentially the same
as that which we reported for citrate inhibition [30, 33, 34]
on this same face and is based on the classic model of
Cabrera and Vermilyea [35]. The essential physics behind
this model is the Gibbs-Thomson effect, which says that
the equilibrium activity of a solute in solution is a function
of the curvature of the solid-solution interface [36]. A
highly curved surface is more soluble than a ﬂat interface.
The same is true for steps. A straight step can grow at a
solute concentration at which a curved step cannot. Thus
for any solute concentration, there is a critical radius of
curvature such that less curved steps can grow but more
curved steps cannot. That critical radius scales inversely
with supersaturation.
In the case of the peptides, they adsorb to the surface
and pin the advancing step. Between the pinning sites, the
step segments bulge out as they try to advance and thus
become curved. At low supersaturation, the critical radius
of curvature is greater than the average spacing between
the pinning sites and the step cannot advance. The result is
that there is a region of positive supersaturation, known as
the ‘‘dead zone,’’ where no growth occurs. At high super-
saturation, the critical radius drops until the steps can close
around the pinning sites without exceeding the critical
radius of curvature. Beyond that supersaturation, the step
speed rapidly rises. The details of this analysis are beyond
the scope of this paper, but we show elsewhere that the
observed behavior can be quantitatively described with a
slight modiﬁcation of the original Cabrera-Vermilyea
model to take into account the much slower adsorption
rates expected for these much larger molecules. The solid
curve through the data points for the ( 101) face in Fig. 10a
shows the ﬁt of the model to the data.
Theeffectofboththepeptidesandproteinsonthekinetics
of the (010) face is clearly more complicated. But the fact
that both exhibit a transition from inhibition to acceleration
with increasing supersaturation establishes a link between
the two. To better understand the behavior, consider the
dependence ofstepspeed onpeptide concentrationshownin
Fig. 10b. The stepspeed risesat a low peptide concentration
andthen drops towards zeroas the peptide level continuesto
increase. Most of the step speed curves for this face in the
presenceofTHPexhibitthesamequalitativebehavior:arise
to a maximum and then a decrease with increasing peptide
concentration, but the magnitude of the effects is less
Fig. 11 Time sequence showing extensive step pinning during
growth of the ( 101) face after introduction of (DDDG)6DDD. Image
sizes are all 150 9 75 nm. Frame interval is 8.4 s
c
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123dramatic.Moresigniﬁcantly,thebehaviorseeninFig. 10bis
precisely the behavior observed for calcite growth in the
presence of D, poly-D, Asp dipeptides, and (DDDX)6DDD
for X = S and G [30]. In the case of Dn, where n was varied
from 1 to 6, analysis showed that the inhibition was well
described by a simple Langmuir adsorption model in which
peptides did not bind strongly enough to pin steps but just
reducedthenumberofactivekinksites[37].Astheimagesin
Fig. 9show,inthecaseofthepeptides,thedensityofclusters
increases with peptide level. And although the individual
peptidesapparentlydonotbindtothestep,theclusterscreate
a physical barrier to step propagation by blocking solute
attachment. At a low peptide concentration, where the
aggregate density is low, they provide little impedance to
step motion. But at sufﬁciently high protein concentrations,
thedensityoftheseclustersbecomestoogreatforthestepsto
advance freely and they must squeeze between the many
clusters. Thus growth is inhibited. Although we do not see
clusters in the case of THP on the (010) face, by comparison
to the calcite system and the COM-(DDDX)6DDD system,
we can surmise that THP does not bind strongly to steps but
presents a barrier to solute attachment at the steps.
To explain the acceleration, consider two observations.
First, acceleration in the calcite system was shown to scale
with both peptide charge and hydrophilicity and required a
reduction in activation energy of as little as 0.015 kJ 9
mol
-1 for aspartic acid to as much as 2.5 kJ 9 mol
-1 for
an acidic 8-kDa protein. From the dependence of calcite
enhancement on peptide charge and hydrophilicity, Elhadj
et al. [31, 37] argued that the peptides modify the local
potential and solution structure near the crystal–liquid
interface. Second, the COM (010) face is negatively
charged due to the oxalate groups that protrude from the
surface. But the peptides are highly anionic due to the 21
aspartic acid residues, each of which presents a carboxyl
side group. One way the peptide clusters can form on this
surface is to bring along an associated cloud of cations to
balance the charge. This would also be true of individual
solvated peptides in solution; to approach the surface, they
would need to bring a counter-ion swarm along. This
precise effect was recently predicted by a computational
study of barite growth in the presence of aspartic acid [38].
The simulations predicted that the aspartic acid molecules
would spontaneously associate with Ba
2? cations and assist
their permeation through the solution as well as their
attachment to the barite surface (cation bridging). Our
conjecture is that this same process is taking place with
COM. At low peptide concentrations where the density of
clusters is too low to cause signiﬁcant inhibition, the
peptides in solution near the surface provide a supply of
Ca
2? that enhances the growth rate. From the similarity of
the results for the peptides and THP, by inference, we
suggest that this picture should be extended to THP.
Even with the obvious source of both cations and anions
to balance charge in these systems, the reason why proteins
and peptides form surface aggregates when the electrostatic
interactions are unfavorable is not obvious. One point to
consider, however, is that, in solution, protein aggregation
is driven by elimination of hydrophobic surfaces [39], not
by speciﬁc bonds or electrostatic interactions. Moreover, as
peptides get larger, they begin to exhibit properties of
colloids, which also aggregate due to solvent effects, spe-
ciﬁcally osmotic forces associated with the increase in free
volume of water brought about by condensation of the
colloids [40]. When a surface is placed into a colloidal
solution, even at colloid concentrations below the critical
volume fraction, they will condense onto the surface for the
same reason [41]. One should expect proteins to exhibit
similar behavior. Consequently, the formation of OPN,
THP, and (DDDX)6DDD aggregates on the charged sur-
face of COM is likely driven by a combination of
electrostatic and osmotic forces whose magnitudes and
effects involve the complete set of constituents: water,
solute ions, proteins, and mineral surface.
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